TB500 (Thymosin Beta-4): Actin Dynamics, Angiogenesis, and Tissue Repair Research
Thymosin Beta-4 (TB4), commercially referenced as TB500 in research settings, is one of the most abundant and ubiquitous intracellular peptides in the human body. Present in virtually every cell type, TB4 plays a central role in cytoskeletal dynamics, cell migration, and tissue repair — making it a foundational compound in regenerative biology and wound healing research.
What Is TB500 (Thymosin Beta-4)?
Thymosin Beta-4 is a naturally occurring 43-amino acid peptide encoded by the TMSB4X gene. It was first isolated from thymic tissue but is now known to be expressed ubiquitously across virtually all cell types. Its primary biological role is as the major actin-sequestering molecule in eukaryotic cells, binding G-actin monomers and regulating the dynamic equilibrium between monomeric and filamentous actin.
Key Areas of In Vitro Research
Actin Sequestration and Cytoskeletal Dynamics
TB4’s most well-characterized function is its role as the primary G-actin sequestering peptide in cells. In vitro studies have demonstrated that TB4 binds actin monomers with high affinity, regulating the pool of available actin for polymerization. This control over cytoskeletal dynamics has downstream effects on cell shape, motility, and division — making TB4 an essential research tool for studying cytoskeletal biology.
Cell Migration and Wound Healing
In vitro scratch assay studies have consistently demonstrated that TB4 significantly accelerates cell migration in multiple cell line models including keratinocytes, fibroblasts, and endothelial cells. Research has shown that TB4-treated cells exhibit enhanced lamellipodia formation and directional migration, key processes in wound closure and tissue repair. These findings have established TB4 as a benchmark compound in wound healing research.
Angiogenesis via VEGF Pathways
TB4 has been studied extensively for its pro-angiogenic properties. In vitro research has demonstrated that TB4 upregulates VEGF (vascular endothelial growth factor) expression and promotes endothelial cell tube formation in Matrigel assays. Studies have also examined its activation of the PI3K/Akt signaling pathway in endothelial cells, providing mechanistic insight into its angiogenic activity.
Anti-Inflammatory Effects
In vitro research has investigated TB4’s ability to reduce pro-inflammatory cytokine production in macrophage and epithelial cell models. Studies have shown decreased NF-κB activation and reduced IL-1β, TNF-α, and IL-6 secretion in TB4-treated cell lines, positioning it as a valuable tool for studying peptide-mediated anti-inflammatory mechanisms.
MMP Upregulation and Matrix Remodeling
TB4 has been shown in vitro to upregulate matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, which are critical for extracellular matrix remodeling during tissue repair. This MMP-stimulating activity, combined with its cell migration-promoting effects, makes TB4 a comprehensive research tool for studying the multi-step process of tissue regeneration at the cellular level.
TB500 in Combination Research Blends
TB500 is also available in combination research formulations at Everlast Peptides. The WOLVERINE 10MG blend (BPC-157 5mg + TB4 5mg) allows researchers to study synergistic interactions between two of the most studied regenerative peptides. The GLOW blend (BPC-157 10mg + GHK-Cu 50mg + TB4 10mg) provides a triple-peptide tool for comprehensive skin biology and tissue repair research.
TB500 at Everlast Peptides
Everlast Peptides supplies TB500 (Thymosin Beta-4) as a high-purity (≥98% HPLC verified) lyophilized powder in 10mg quantities, providing researchers with a reliable source for cytoskeletal, wound healing, and angiogenesis studies.
Research Compliance Note
All TB500 products from Everlast Peptides are strictly for in vitro laboratory research use only. Not for human or veterinary use. Use only in certified laboratory environments under proper compliance.
Everlast Peptides supplies high-purity lyophilized research compounds for qualified laboratory professionals. All products are for in vitro research use only.
Ipamorelin: The Selective Growth Hormone Secretagogue in Preclinical Research
Among the growth hormone secretagogues studied in preclinical research, Ipamorelin stands out for its exceptional receptor selectivity. Unlike earlier GH-releasing peptides, Ipamorelin stimulates GH release without significantly affecting cortisol, prolactin, or ACTH levels in cell-based assays — a profile that has made it one of the most widely used tools for studying the somatotropic axis in isolation.
What Is Ipamorelin?
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) and selective agonist of the ghrelin receptor (GHS-R1a). Developed in the 1990s, it was among the first GH secretagogues to demonstrate high GH-releasing potency combined with a clean side-effect profile in preclinical models, distinguishing it from earlier compounds like GHRP-2 and GHRP-6.
Key Areas of In Vitro Research
Ghrelin Receptor (GHS-R1a) Binding and Selectivity
In vitro binding studies have characterized Ipamorelin’s high affinity and selectivity for the GHS-R1a receptor. Radioligand binding assays have demonstrated its potent displacement of ghrelin at the receptor, while functional assays in pituitary cell lines have confirmed robust GH secretion with minimal activation of off-target receptors. This selectivity profile makes Ipamorelin a preferred tool for receptor pharmacology research.
GH Axis Stimulation Without Cortisol Elevation
A defining characteristic of Ipamorelin in preclinical research is its ability to stimulate GH release without triggering ACTH or cortisol secretion — a limitation of earlier GHRPs. In vitro studies using pituitary and adrenal cell line models have confirmed this selectivity, making Ipamorelin valuable for researchers who need to study GH axis activation in isolation from HPA axis confounders.
IGF-1 Downstream Signaling
Research has examined Ipamorelin’s downstream effects on IGF-1 expression in hepatocyte and muscle cell models. In vitro studies have demonstrated that GHS-R1a activation by Ipamorelin leads to measurable increases in IGF-1 mRNA expression, providing a cellular model for studying the GH/IGF-1 axis and its anabolic signaling cascades.
Synergistic Research with CJC-1295
Ipamorelin is frequently studied in combination with CJC-1295 (no DAC) to investigate dual-pathway GH axis activation. The IPAM + CJC no DAC blend available from Everlast Peptides provides researchers with a pre-formulated tool for studying the additive effects of simultaneous GHRH receptor and ghrelin receptor activation in cell culture models.
Ipamorelin at Everlast Peptides
Everlast Peptides supplies Ipamorelin as a high-purity (≥98% HPLC verified) lyophilized powder in 10mg quantities. It is also available in combination blends: IPAM + CJC no DAC and IPAM + TESA (with Tesamorelin) for multi-pathway research designs.
Research Compliance Note
All Ipamorelin products from Everlast Peptides are strictly for in vitro laboratory research use only. Not for human or veterinary use. Use only in certified laboratory environments under proper compliance.
Everlast Peptides supplies high-purity lyophilized research compounds for qualified laboratory professionals. All products are for in vitro research use only.
Epithalon (Epitalon): Telomerase Activation and Cellular Aging Research
Epithalon — also known as Epitalon — is a synthetic tetrapeptide that has attracted significant attention in geroscience and cellular aging research. Derived from the natural peptide Epithalamin produced by the pineal gland, Epithalon has been studied for its remarkable ability to activate telomerase and influence telomere dynamics in somatic cells, placing it at the frontier of longevity biology research.
What Is Epithalon?
Epithalon is a tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). It was developed by the St. Petersburg Institute of Bioregulation and Gerontology and has been the subject of decades of preclinical research. Its small size, stability, and well-characterized biological activity make it a practical and reproducible tool for in vitro aging research.
Key Areas of In Vitro Research
Telomerase Activation
The most extensively studied property of Epithalon in cell culture models is its ability to activate telomerase (hTERT), the enzyme responsible for maintaining telomere length. In vitro studies have demonstrated that Epithalon treatment in somatic cell lines — which normally lack telomerase activity — can induce measurable telomerase expression, resulting in telomere elongation. This finding has made Epithalon one of the most important research tools in the study of cellular senescence and replicative aging.
Telomere Length and Cellular Senescence
Telomere shortening is a hallmark of cellular aging, with critically short telomeres triggering replicative senescence and apoptosis. In vitro research has explored Epithalon’s ability to extend the replicative lifespan of human fetal fibroblast cell lines by maintaining telomere length above the critical threshold. These studies provide a cellular model for investigating the relationship between telomere dynamics and the aging phenotype.
Antioxidant Activity
Beyond telomerase activation, in vitro studies have investigated Epithalon’s antioxidant properties. Research has demonstrated its ability to reduce oxidative stress markers in cell culture models, including decreased lipid peroxidation and enhanced superoxide dismutase (SOD) activity. These findings suggest a multi-mechanism approach to studying cellular protection against age-related oxidative damage.
Melatonin Regulation
Epithalon has been studied for its role in regulating pineal gland function and melatonin synthesis. In vitro research has examined its effects on melatonin production in pinealocyte cell models, with implications for understanding circadian rhythm regulation and the neuroendocrine aspects of aging biology.
Epithalon at Everlast Peptides
Everlast Peptides supplies Epithalon as a high-purity (≥98% HPLC verified) lyophilized powder in 10mg quantities, providing researchers with a reliable and consistent source for telomere and aging biology studies.
Research Compliance Note
All Epithalon products from Everlast Peptides are strictly for in vitro laboratory research use only. Not for human or veterinary use. Use only in certified laboratory environments under proper compliance.
Everlast Peptides supplies high-purity lyophilized research compounds for qualified laboratory professionals. All products are for in vitro research use only.
Melanotan II (MT-2): Melanocortin Receptor Pharmacology and Pigmentation Research
Melanotan II (MT-2) is one of the most studied synthetic melanocortin receptor agonists in preclinical research. A cyclic analog of alpha-melanocyte-stimulating hormone (α-MSH), MT-2 has been investigated across a broad range of in vitro applications — from pigmentation biology and receptor pharmacology to energy homeostasis and neuroendocrine signaling research.
What Is Melanotan II?
MT-2 is a cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2) developed at the University of Arizona as a more potent and stable analog of α-MSH. Its cyclic structure confers resistance to enzymatic degradation and enhanced receptor binding affinity compared to the linear α-MSH sequence, making it a practical and reproducible tool for melanocortin receptor research.
Key Areas of In Vitro Research
Melanocortin Receptor Binding and Pharmacology
MT-2 is a non-selective melanocortin receptor agonist with activity at MC1R, MC3R, MC4R, and MC5R. In vitro binding studies using radioligand displacement assays have characterized its binding affinities across the melanocortin receptor family. Functional assays in receptor-expressing cell lines have demonstrated potent cAMP accumulation downstream of receptor activation, making MT-2 a valuable pharmacological tool for studying melanocortin receptor signaling cascades.
MC1R and Melanogenesis
The most extensively studied application of MT-2 in cell culture is its activation of MC1R in melanocyte cell lines. In vitro research has demonstrated that MT-2-induced MC1R activation leads to robust upregulation of tyrosinase activity and melanin synthesis via the cAMP/PKA/MITF signaling pathway. These studies have established MT-2 as a benchmark agonist for studying UV-independent pigmentation mechanisms and melanocyte biology.
MC4R and Energy Homeostasis Research
MT-2’s activity at MC4R has made it a widely used tool in metabolic biology research. In vitro studies using hypothalamic and neuronal cell lines have examined MC4R-mediated signaling pathways involved in energy balance regulation. Research has explored MT-2’s effects on neuropeptide Y (NPY) and POMC expression in hypothalamic cell models, providing cellular insights into appetite-regulating hormone cascades.
Comparative Studies with MT-1 (Melanotan I)
MT-2’s broad melanocortin receptor activity profile contrasts with the MC1R selectivity of MT-1 (Melanotan I / Afamelanotide). In vitro comparative studies using both compounds allow researchers to dissect receptor subtype-specific signaling — MT-1 for MC1R-selective pigmentation research and MT-2 for broader melanocortin system investigations. Both compounds are available from Everlast Peptides for comparative experimental designs.
MT-2 at Everlast Peptides
Everlast Peptides supplies MT-2 (Melanotan II) as a high-purity (≥98% HPLC verified) lyophilized powder in 10mg quantities. MT-1 (Melanotan I) is also available for researchers requiring MC1R-selective comparative studies.
Research Compliance Note
All MT-2 products from Everlast Peptides are strictly for in vitro laboratory research use only. Not for human or veterinary use. Use only in certified laboratory environments under proper compliance.
Everlast Peptides supplies high-purity lyophilized research compounds for qualified laboratory professionals. All products are for in vitro research use only.
NAD+: The Coenzyme at the Center of Aging and Longevity Research
Nicotinamide Adenine Dinucleotide (NAD+) has emerged as one of the most intensively studied molecules in modern geroscience. Found in every living cell, this critical coenzyme sits at the intersection of energy metabolism, DNA repair, and cellular aging — making it a foundational compound for researchers exploring the biology of longevity.
What Is NAD+?
NAD+ is a dinucleotide coenzyme composed of two nucleotides joined by phosphate groups. It exists in two forms — NAD+ (oxidized) and NADH (reduced) — and cycles between these states as it shuttles electrons during metabolic reactions. Beyond its role in energy metabolism, NAD+ serves as a substrate for several critical enzyme families including sirtuins (SIRTs), PARPs, and CD38.
Key Areas of In Vitro Research
Mitochondrial Function and Energy Metabolism
NAD+ is indispensable for the citric acid cycle and oxidative phosphorylation. In vitro research has demonstrated that declining intracellular NAD+ levels impair mitochondrial function in aged cell lines, while NAD+ supplementation in cell culture models restores mitochondrial membrane potential and ATP production. These findings have positioned NAD+ as a central target in metabolic biology research.
Sirtuin Activation
Sirtuins (SIRT1–SIRT7) are NAD+-dependent deacetylases that regulate gene expression, DNA repair, and metabolic homeostasis. In vitro studies have shown that NAD+ availability directly controls sirtuin activity — when NAD+ levels drop, sirtuin function is impaired. Research using cell culture models has explored how restoring NAD+ reactivates SIRT1 and SIRT3, with downstream effects on mitochondrial biogenesis and stress resistance pathways.
PARP Enzyme Activity and DNA Repair
PARP (Poly ADP-ribose polymerase) enzymes consume NAD+ as a substrate during DNA damage repair. In vitro research has examined the competitive relationship between PARP activation and sirtuin function — excessive DNA damage triggers PARP hyperactivation, rapidly depleting cellular NAD+ and impairing sirtuin-mediated protective pathways. This NAD+/PARP/sirtuin axis is an active area of investigation in aging and cancer biology research.
NAD+ Precursor Pathways
In vitro studies have extensively compared NAD+ precursors including NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) for their ability to raise intracellular NAD+ levels. Direct NAD+ supplementation in cell culture provides researchers with a tool for studying NAD+ biology without the confounding variables introduced by precursor conversion efficiency differences between cell types.
NAD+ Research Formulations at Everlast Peptides
Everlast Peptides supplies NAD+ as a high-purity (≥98% HPLC verified) lyophilized powder in 250mg and 500mg quantities, providing researchers with flexible options for dose-response studies and extended experimental protocols.
Research Compliance Note
All NAD+ products from Everlast Peptides are strictly for in vitro laboratory research use only. Not for human or veterinary use. Use only in certified laboratory environments under proper compliance.
Everlast Peptides supplies high-purity lyophilized research compounds for qualified laboratory professionals. All products are for in vitro research use only.
BPC-157: What Researchers Need to Know About This Versatile Peptide
Few peptides have generated as much preclinical research interest as BPC-157 (Body Protection Compound-157). Originally derived from a protective protein found in gastric juice, this synthetic pentadecapeptide has become a cornerstone compound in regenerative biology, angiogenesis research, and cellular repair studies. Here's a comprehensive overview of what the current in vitro literature tells us.
What Is BPC-157?
BPC-157 is a 15-amino acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that was isolated from human gastric juice. Its stability in aqueous environments and resistance to enzymatic degradation have made it a practical and widely used tool in laboratory research settings.
Key Areas of In Vitro Research
Angiogenesis and Vascular Biology
One of the most studied properties of BPC-157 in cell culture models is its ability to promote angiogenesis. Research has demonstrated that BPC-157 upregulates VEGF (vascular endothelial growth factor) expression and stimulates endothelial cell migration and tube formation in vitro. These findings have made it a valuable tool for researchers studying wound healing and vascular biology.
Fibroblast Activity and Tissue Remodeling
In vitro studies have shown that BPC-157 significantly enhances fibroblast migration and proliferation. Research using scratch assay models has demonstrated accelerated wound closure in fibroblast monolayers treated with BPC-157, suggesting its utility as a research tool for studying connective tissue biology and extracellular matrix remodeling.
Nitric Oxide (NO) Pathway Modulation
BPC-157 has been investigated for its interaction with the nitric oxide system. In vitro research has explored its ability to modulate eNOS (endothelial nitric oxide synthase) activity, with implications for understanding vascular tone regulation and cytoprotective mechanisms at the cellular level.
Growth Hormone Receptor Interaction
Emerging research has examined BPC-157's interaction with growth hormone receptors, suggesting potential cross-talk between gastric peptide signaling and the somatotropic axis. This represents an active and evolving area of in vitro investigation.
Research Formulations Available
BPC-157 is available in several research formulations depending on the experimental design. Standard lyophilized BPC-157 (10mg) is the most commonly used format for in vitro studies. For researchers interested in studying synergistic peptide interactions, combination blends such as WOLVERINE 10MG (BPC-157 + TB500) and GLOW (BPC-157 + GHK-Cu + TB4) provide multi-pathway research tools in a single compound.
Reconstitution for In Vitro Use
For in vitro applications, BPC-157 lyophilized powder should be reconstituted using bacteriostatic water or sterile PBS, depending on the assay requirements. Proper reconstitution technique is critical for maintaining compound integrity and ensuring reproducible results across experiments.
Important Research Compliance Note
All BPC-157 products available through Everlast Peptides are strictly for in vitro laboratory research use only. They are not intended for human or veterinary use, and should only be handled in certified laboratory environments under appropriate regulatory compliance frameworks.
Everlast Peptides supplies high-purity (≥98% HPLC verified) lyophilized research peptides for qualified laboratory professionals. All products are for in vitro research use only.